
Glenn J Lesser MD
Neuro-Oncology
Professor of Hematology & Oncology, Wake Forest University
Join to view full profile
S Hawthorne RdWinston-Salem, NC 27157
Phone+1 336-716-2255
Dr. Lesser is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Glenn Lesser, MD, is an oncology specialist based in Winston-Salem, NC, with a subspecialty in neuro-oncology. He completed his fellowship in Hematology and Medical Oncology at Johns Hopkins University and his residency in Internal Medicine at Wake Forest University Baptist Medical Center. He is currently the Deputy Director of the Atrium Health Wake Forest Baptist Comprehensive Cancer Center and the Louise McMichael Miracle Professor of Cancer Medicine. He is also the contact MPI for the Wake Forest NCORP Research Base. Dr. Lesser has extensive experience in neuro-oncology, general medical oncology and supportive care. His research has been published in various scientific journals, including the Journal of Clinical Oncology, Neuro-Oncology and New England Journal of Medicine. He has contributed to over 120 clinical trials focused on novel therapeutics for malignant brain tumors and symptom management issues affecting cancer patients including cancer pain management, cachexia, fatigue and chemotherapy-induced taste disturbances. Dr. Lesser has been recognized as one of America's Top Doctors and as a top doctor for cancer by Castle Connolly for the past two decades. He is board certified in Medical Oncology and he holds CMS certifications for meaningful use of electronic health records.
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1991 - 1994
Wake Forest University Baptist Medical CenterResidency, Internal Medicine, 1987 - 1991
Pennsylvania State University College of MedicineClass of 1987
Certifications & Licensure
NC State Medical License 1995 - 2027
VA State Medical License 1994 - 2012
MD State Medical License 1991 - 1996
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2024
- America's Top Doctors for Cancer Castle Connolly, 2005-2021
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
Clinical Trials
- Pyrazoloacridine Followed by Radiation Therapy in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme
- Oxandrolone Compared With Megestrol in Preventing Weight Loss in Patients Receiving Chemotherapy for Cancer Start of enrollment: 2004 Mar 01
- Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma Start of enrollment: 2004 Jan 01
Publications & Presentations
PubMed
- WF-1801: Single-arm pilot study of ramipril for prevention of radiation-induced cognitive decline in glioblastoma patients receiving chemoradiotherapy.Christina K Cramer, Sydney Smith, Emily V Dressler, Brandi Page, Jeffrey S Wefel
Neuro-Oncology Practice. 2026-10-01 - Work Ability in Young Adult Survivors (WAYS WF-10217): Documenting Labor Force Participation, Occupation, and Educational Attainment Following Cancer Treatment.Karly M Ingram, Janet A Tooze, Sharon M Castellino, Katherine A McLean, John M Salsman
Journal of Adolescent and Young Adult Oncology. 2026-10-01 - Multi-site feasibility of a web-based and telephone navigation intervention to connect lung cancer caregivers in community oncology settings with resources: Protocol f...Chandylen L Nightingale, Anna C Snavely, Beverly J Levine, Julie C Turner, Michael K Farris
Contemporary Clinical Trials. 2026-09-01
Press Mentions
Cancer Researchers at Wake Forest Baptist Receive $25 Million from National Cancer InstituteSeptember 23rd, 2019
What Are the Symptoms of Glioblastoma? Brain Cancer Treatment, Survival RatesJuly 17th, 2019
A Randomized, Double-Blind, Placebo-Controlled Study of Oral Coenzyme Q 10 to Relieve Self-Reported Treatment-Related Fatigue in Newly Diagnosed Patients with Breast CancerMarch 1st, 2013
Grant Support
- Wake Forest NCORP Research BaseWAKE FOREST UNIVERSITY HEALTH SCIENCES2014–2027
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: